Site: 001-058

New Haven, Connecticut 06511

1 studies enrolling now · 1 studies all time

What they study most

Advanced or Metastatic Solid Tumors

Studies at this site

• To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors — Recruiting now